In ruminants, both the endometrium and the conceptus (embryo and associated extraembryonic membranes) trophectoderm synthesizes and secretes prostaglandins (PG) during early pregnancy. In mice and humans, PGs regulate endometrial function and conceptus implantation. In Study One, bred ewes received intrauterine infusions of vehicle as a control (CX) or meloxicam (MEL), a PG synthase (PTGS) inhibitor from Days 8-14 postmating, and the uterine lumen was flushed on Day 14 to recover conceptuses and assess their morphology. Elongating and filamentous conceptuses (12 cm to .14 cm in length) were recovered from all CX-treated ewes. In contrast, MEL-treated ewes contained mostly ovoid or tubular conceptuses. PTGS activity in the uterine endometrium and amounts of PGs were substantially lower in uterine flushings from MEL-treated ewes. Receptors for PGE2 and PGF2 alpha were present in both the conceptus and the endometrium, particularly the epithelia. In Study Two, cyclic ewes received intrauterine infusions of CX, MEL, recombinant ovine interferon tau (IFNT), or IFNT and MEL from Days 10-14 postestrus. Infusion of MEL decreased PGs in the uterine lumen and expression of a number of progesteroneinduced endometrial genes, particularly IGFBP1 and HSD11B1. IFNT increased endometrial PTGS activity and the amount of PGs in the uterine lumen. Interestingly, IFNT stimulation of many genes (FGF2, ISG15, RSAD2, CST3, CTSL, GRP, LGALS15, IGFBP1, SLC2A1, SLC5A1, SLC7A2) was reduced by co-infusion with MEL. Thus, PGs are important regulators of conceptus elongation and mediators of endometrial responses to progesterone and IFNT in the ovine uterus.
INTRODUCTION
Maternal support of blastocyst growth and development into an elongated conceptus (embryo/fetus and associated membranes) is critical for pregnancy recognition signaling and implantation in ruminants [1, 2] . After hatching from the zona pellucida on Day 8, the blastocyst develops into an ovoid or tubular form by and is then termed a conceptus [1, 3] . The conceptus begins to elongate on Day 12 and reaches up to 14 cm or more in length by Day 16. Conceptus elongation requires substances secreted from the endometrial luminal (LE) and glandular epithelia (GE) (LE/GE) [4, 5] . During early pregnancy in ruminants, functions of the endometrium are regulated primarily by progesterone from the corpus luteum and secreted factors from the conceptus, including interferon tau (IFNT) [6] [7] [8] [9] . IFNT, produced by the mononuclear trophectoderm cells of the conceptus during elongation, exerts antiluteolytic effects on the endometrium. In both sheep and cattle, IFNT prevents upregulation of oxytocin receptor (OXTR) expression in the LE/superficial GE (sGE), which is required for the endometrium to generate oxytocin-dependent luteolytic pulses of prostaglandin F2a (PGF2a) in response to oxytocin from the corpus luteum, and/or posterior pituitary in nonpregnant ewes. In this way, IFNT maintains corpus luteum function for continued production of progesterone, the unequivocal hormone of pregnancy that stimulates and maintains uterine endometrial functions necessary for conceptus survival and growth [9] .
The sequential and combinatorial effects of progesterone and IFNT on the endometrium result in specific changes in the intrauterine milieu necessary for conceptus elongation and development [2, 8, 10] . In the LE/sGE, progesterone induces the expression of many genes between Days 10 and 12, in both pregnant and nonpregnant ewes, which encode enzymes (PG G/H synthase and cyclooxygenase 2 [PTGS2] and 11-betahydroxysteroid dehydrogenase [HSD11B1]), adhesion proteins (galectin 15 [LGALS15] and insulin-like growth factor binding protein 1 [IGFBP1]), a protease (cathepsin L [CTSL1]), a protease inhibitor (cystatin C3 [CST3]), a cell proliferation factor (gastrin releasing peptide [GRP] ), glucose transporters (SLC2A1 and SLC5A1), and a cationic amino acid (arginine, lysine, and ornithine) transporter (SLC7A2). In the GE, progesterone induces expression of several genes between Days 12 and 14-16, including a cell proliferation factor (GRP) and a glucose transporter (SLC5A11). Of particular note, IFNT induces or increases expression of many genes in the endometrium that regulate conceptus growth and development during the peri-implantation period of pregnancy [2, 8, 10, 11] . In the endometrial LE/sGE of the ovine uterus, IFNT stimulates a number of the progesterone-induced genes that encode enzymes (HSD11B1) and secreted proteins (CST3, CTSL, GRP, IGBP1, LGALS15), as well as transporters for glucose (SLC2A1 and SLC5A11) and amino acids (SLC7A2). In the endometrial GE and stroma, IFNT induces or substantially stimulates expression of a large number of classical IFNstimulated genes (ISGs), including the ISG15 gene and the radical S-adenosyl-containing domain 2 (RSAD2) gene.
Recent studies in sheep clearly support the concept that PGs from the conceptus and/or endometrium regulate expression of, e.g., the IGFBP1 and HSD11B1 genes, in the endometrial LE/ sGE during early pregnancy [12, 13] . In both sheep and cattle, the conceptuses and endometria synthesize a variety of PGs during early pregnancy [14] [15] [16] [17] [18] [19] , and the endometria also contain and produce substantially more PGs during early pregnancy than during the estrous cycle [20, 21] . PTGS2, the dominant cyclooxygenase in both the conceptus trophectoderm and endometrium, can be induced in the endometrium of ovariectomized ewes by progesterone [18] . Thus, the ability of the uterus to synthesize PGs during the estrous cycle and early pregnancy is due to the induction of the PTGS2 gene in the endometrial LE/sGE by progesterone, whose effects on endometrial gene expression may be indirectly mediated by PTGS2-derived PGs. Although IFNT clearly inhibits upregulation of OXTR expression in the endometrial LE/sGE of ewes in early pregnancy, it does not inhibit upregulation of PTGS2, a rate-limiting enzyme in PG synthesis [18, 22] . Indeed, PTGS2 is also not downregulated in endometria of cattle in early pregnancy but rather is upregulated by IFNT [23, 24] . Furthermore, substantial evidence from studies of the bovine uterus indicates that IFNT acts as a molecular switch that stimulates PGE2 production in the endometrium [25] . In fact, type I IFNs were found to stimulate phospholipase A2 (PLA2) and synthesis of PGE2 and PGF2a in several different cell types over 25 years ago [26, 27] . Thus, PGs may mediate the effects of progesterone and IFNT on gene expression and function in the ruminant uterus.
Available results indicate that PGs from the conceptus and perhaps the endometrium itself have autocrine, paracrine, and perhaps intracrine effects on conceptus development, endometrial function, and endometrial responses to progesterone and IFNT in ruminants. As a first step in testing that hypothesis, two studies were conducted using sheep as a model ruminant to determine 1) the effect of inhibiting PTGS2 in utero on conceptus development and endometrial gene expression and 2) the biological roles of PGs in endometrial function and response to IFNT.
MATERIALS AND METHODS

Experimental Design
Mature Rambouillet ewes (Ovis aries) were observed for estrus (designated as Day 0) in the presence of a vasectomized ram and used in experiments only after exhibiting at least two estrous cycles of normal duration (16-18 days 
Study One
Ewes (n¼10) were mated at estrus (Day 0) to rams of proven fertility. On Day 8 postmating, the ewes were subjected to a mid-ventral laparotomy. Using methods described previously [28, 29] , the base of the uterine horn ipsilateral to the corpus luteum was double ligated using nonabsorbable umbilical tape to prevent migration and growth of the conceptus through the uterine body into the contralateral uterine horn; this surgical procedure does not affect conceptus implantation or development in sheep. A vinyl catheter (item no. 0007760; Durect Corp., Cupertino, CA) connected to a preloaded and equilibrated Alzet 2ML1 osmotic pump (Durect Corp.) was then inserted about 1 cm distal to the tubouterine junction into the lumen of the uterine horn ipsilateral to the ovary (Fig.  1 ). The Alzet pump was then affixed to the mesometrial ligament between the uterine horn and oviduct by using cyanoacrylate glue (Super Glue; Bentonville, AR) and then secured by sewing the oviduct to the perimetrium of the uterine horn, using 0 coated polyglactin suture (Vicryl; Ethicon, Somerville, NJ).
Ewes (n ¼ 5 per treatment) received osmotic pumps containing either vehicle control (CX) (2 ml of 2% ethanol saline) or meloxicam (MEL) (1225 ng in 2 ml of vehicle; Boehringer Ingelheim Pharmaceuticals, St. Joseph, MO), a partially selective PTGS2 inhibitor (13.1 times more inhibitory for PTGS2 than PTGS1) [30] that is effective in sheep [31] [32] [33] [34] [35] [36] . The Alzet 2ML1 osmotic pump constantly delivers 10 ll per h (240 ll/day) for 7 days. All ewes were euthanized on Day 14 postmating to obtain the uterus. The ipsilateral uterine horn was flushed with 10 ml of 10 mM Tris (pH 7.2), and the state of blastocyst/conceptus development was visually assessed and recorded. The volume of the uterine flushing was measured and recorded and then clarified by centrifugation (3000 3 g at 48C for 15 min). The supernatant was carefully removed with a pipette, aliquoted, frozen in liquid nitrogen, and stored at À808C. Several sections (;0.5 cm) from the mid-portion of each uterine horn were fixed in fresh 4% paraformaldehyde in PBS (pH 7.2). After 24 h, fixed tissues were changed to 70% ethanol for 24 h and then dehydrated and embedded in Paraplast-Plus (Oxford Labware, St. Louis, MO). The remaining endometrium was physically dissected from myometrium, frozen in liquid nitrogen, and stored at À808C for subsequent RNA extraction.
Study Two
Ewes (n ¼ 24) were detected in estrus (Day 0) using a vasectomized ram. On Day 10 postestrus, ewes were subjected to a mid-ventral laparotomy, and the lumen of each uterine horn received a vinyl catheter connected to an Alzet 2ML1 osmotic pump that was implanted as described for Study One. Ewes (n ¼ 6 per treatment) received pumps containing either CX (2 ml of 2% ethanol saline and 101 lg of ovine serum proteins), recombinant ovine IFNT (101 lg in 2 ml of vehicle) [37] , MEL (1225 ng in 2 ml of vehicle and 101 lg of ovine serum proteins; Boehringer Ingelheim Pharmaceuticals, St. Joseph, MO), or recombinant ovine IFNT and MEL (IFNTþMEL). Recombinant ovine IFNT was produced in Pichia pastoris and purified as described previously [37] . Serum proteins and IFNT were prepared for intrauterine injections as described previously [38] . The amount of recombinant ovine IFNT was based on published estimates of IFNT production by Day-14 ovine conceptuses, which is about 600 ng per h or 14.4 lg per day [39] . Intrauterine infusion of that amount of IFNT mimics effects of the conceptus on endometrial expression of hormone receptors and IFNT-stimulated genes during early pregnancy in ewes [40] . All ewes were necropsied on Day 14, and uterine flushings and uteri were obtained and processed as described for Study One.
Total RNA Isolation and Real-Time PCR Analysis
Total RNA was isolated from endometrial samples using TRIzol reagent (Gibco-BRL, Bethesda, MD) according to the manufacturer's protocol. To eliminate genomic DNA contamination, extracted RNA was treated with DNase I and purified using RNeasy MinElute cleanup kit (Qiagen, Valencia, CA). The quantity and quality of total RNA were determined by spectrometry and denaturing agarose gel electrophoresis, respectively.
Total RNA from each sample was reverse transcribed in a total reaction volume of 20 ll. Briefly, total RNA (4 lg) was combined with primer mixture containing oligo(dT) primer (0.2 lg/ml), random hexamer primer (300 lg/ml) (Invitrogen, Carlsbad, CA), and a mixture of deoxynucleotides (10 mM each) and incubated at 658C for 5 min. A reverse transcription mixture containing 53 first-strand buffer, 0.1 M dithiothreitol and SuperScript II reverse transcriptase (Invitrogen) was added to the reaction mixture, and reverse transcription was performed under the following conditions: 258C for 10 min, 428C for 60 min, and 708C for 5 min. Mixtures without reverse transcriptase were prepared for each sample to test for genomic DNA contamination. The resulting cDNA was stored at À208C for further analysis.
Real-time PCR was performed using an ABI prism 7900HT system (Applied Biosystems, Foster, CA) with Power SYBR Green PCR Master Mix (Applied Biosystems, Foster, CA). Specific oligonucleotide primers were designed by Oligo 5 software (Molecular Biology Insights, Inc.) (see Supplemental Table S1 , available online at www.biolreprod.org). Primer specificity and efficiency (À3.6 . slope . À3.1) were confirmed by using a test amplification run. Each individual sample was run in triplicate, using the following conditions: 508C for 2 min, 958C for 10 min, and then 958C for 15 sec and 608C for 1 min for 40 cycles. A dissociation curve was generated at the end of amplification to ensure that a single product was amplified. PCR without template or template substituted with total RNA was used as a negative control to verify experimental results. The threshold line was set in the linear region of 
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the plots above the baseline noise, and threshold cycle (Ct) values were determined as the cycle numbers at which the threshold lines crossed the amplification curve. Ovine GAPDH gene was used as the reference gene.
Enzyme Immunoassay of PGs
Sensitive enzyme immunoassay (EIA) kits were purchased from Cayman Chemical (Ann Arbor, MI), and the contents of total PGs (catalog no. 514012), PGE2 (catalog no. 514010), PGF2a (catalog no. 516011), and 6-keto-PGF1a (catalog no. 515211) in the uterine flush were measured according to the manufacturer's recommendations. Assay sensitivity for total PGs was 15.6 pg/ ml, and the intra-and interassay coefficients of variation (CV) were 2.2% and 5.7%, respectively. Assay sensitivity for PGE2 was 8.7 pg/ml, and the intraand interassay CV were 2.5% and 4.0%, respectively. Assay sensitivity for PGF2a was 3.0 pg/ml, and the intra-and interassay CV were 0.9% and 7.7%, respectively. Assay sensitivity for 6-keto-PGF1a was 1.6 pg/ml, and the intraand interassay CV were 3.6% and 5.4%, respectively. The data are expressed as total amounts in the uterine flush, determined by multiplying assay results by the recovered volume of uterine flushing.
Fluorescence Activity Assay of Endometrial PG Synthase Activity
Endometrial tissue (1 g) was placed in ice cold buffer containing 100 mM Tris-HCl (pH 7.5), 500 lM 4-(2-Aminoethyl)benzenesulfonyl fluoride, 150 nM aprotinin, 1 lM E-64 protease inhibitor, 0.5 mM EDTA, and 1 lM leupeptin and then homogenized for 5 min using a tissue homogenizer. Homogenates were then clarified by centrifugation (10 000 3 g for 15 min at 48C). The protein content in the supernatant was determined using a Bio-Rad Bradford protein assay (Burlingame, CA). The supernatant was aliquoted and then stored at À808C. Endometrial PTGS2 activity was measured using a cyclooxygenase fluorescent activity assay (item 700200; Cayman Chemical, Ann Arbor, MI) performed according to the manufacturer's recommendation. The intra-and interassay CV were 7.9% and 7.3%, respectively. The data are expressed as nmol/min.
Immunohistochemical Analyses
Immunoreactive PTGS2, PTGER2, PTGER4, and PTGFR proteins were localized in ovine uteri from Study Two by using specific antibodies and a rabbit Vectastain ABC Elite kit (Vector Laboratories, Burlingame, CA). In addition, PTGER2, PTGER4, and PTGFR proteins were localized in paraformaldehydefixed and paraffin-embedded uteri from Day 14, 16, 18, and 20 pregnant ewes (n¼ 5 ewes per day) collected as previously described [41] . The following polyclonal antibodies from Cayman Chemical (Ann Arbor, MI) were used: rabbit antimurine PTGS2 polyclonal antibody (catalog no. 160106) was used at a 1:250 final dilution; rabbit anti-human PTGER2 polyclonal antibody (catalog no. 101750) was used at a 1:500 final dilution; rabbit anti-human PTGER4 polyclonal antibody (catalog no. 101775) was used at a 1:250 final dilution; and rabbit antihuman PTGFR polyclonal antibody (code P8622; Sigma) was used at 1:1500 final dilution. Antigen retrieval was performed using the boiling citrate method described previously [41] . Negative controls included substitution of the primary antibody with purified nonimmune rabbit immunoglobulin G at the same final concentration. Sections were not counterstained prior to affixing coverslips. Photomicrographs were taken using a Nikon Eclipse E1000 photomicroscope (Nikon Instruments, Melville, NY). Digital images were captured using a Nikon DXM 1200 digital camera and assembled using Adobe Photoshop 7.0 (Adobe Systems, Seattle, WA).
Statistical Analysis
All quantitative data were subjected to least squares analyses of variance (ANOVA) using the general linear models procedures of the Statistical Analysis System software (SAS Institute Inc., Cary, NC). In Study Two, preplanned orthogonal contrasts were used to determine effects of treatment (CX vs. MEL, CX vs. IFNT, IFNT vs. IFNTþMEL). In all analyses, error terms used in tests of significance were identified according to the expectation of the mean squares for error. If necessary, the data were log transformed prior to analysis to alleviate heterogeneity of error variance. Significance (P , 0.05) was determined by probability differences of least squares means. The data are presented as least squares means and overall standard error of the means (SEM).
RESULTS
Intrauterine Infusion of PTGS2 Inhibitor Inhibits Conceptus
Study One tested the hypothesis that PGs from the conceptus and/or endometrium regulate conceptus elongation during the peri-implantation period of early pregnancy in sheep. The uterus was obtained on Day 14 postmating. Elongating and filamentous conceptuses (12 cm to .14 cm in length) were recovered from all ewes receiving CX (n ¼ 5/5). In contrast, either ovoid (;2 mm; n ¼ 3), tubular (;1 cm; n ¼ 1), or a very fragile and fragmented but elongated (n ¼ 1) conceptus was recovered from ewes receiving the PTGS2 inhibitor MEL.
As summarized in Table 1 , total PTGS and PTGS2 activity levels were higher (P , 0.01) in the endometria of CX-treated ewes than in those of MEL-treated ewes. PTGS2 activity constituted 89.4% and 66.5% of total PTGS activity in endometria from CX-and MEL-treated ewes, respectively. In order to measure total PGs, an EIA that exhibits high cross reactivity for most PGs was used. As summarized in Table 1 , total PGs were approximately 40-fold higher (P , 0.01) in the uterine lumen of CX-treated ewes than in those of MEL-treated ewes. Next, results of specific EIAs revealed that the amounts of PGE2, PGF2a, and 6-keto-PGF1a (an indicator of prostacyclin [PGI2]) were approximately 60-, 40-, and 19-fold greater (P , 0.01) in the uterine flushings from CX-treated ewes than in those from MEL-treated ewes.
Immunoreactive PTGER2, PTGER4, and PTGFR proteins were detected predominantly in the conceptus trophectoderm and endometrial epithelia on Days 14, 16, 18, and 20 of pregnancy (Supplemental Fig. S1 ). In the endometrium, the PTGER2, PTGER4, and PTGFR proteins were most abundant in the endometrial epithelia but were also observed in the stroma and myometrium (data not shown). Of note, the overall abundance of all three receptors was greatest in the endometrial epithelia on Days 14 and 20 of pregnancy.
IFNT Increases Endometrial Production of PGs and PTGS2 Activity in Cyclic Ewes (Study Two)
Study Two was conducted to test the hypothesis that effects of IFNT on endometrial functions are mediated by PGs. As summarized in Table 2 , total PTGS and PTGS2 activity was greater (P , 0.01) in endometria from IFNT-treated ewes than in that from CX-treated ewes. Total PTGS and PTGS2 PROSTAGLANDINS REGULATE CONCEPTUS ELONGATION activities were low in endometria from CX ewes and not different (P . 0.10) from those in MEL ewes. However, total PTGS and PTGS2 activities were greater (P , 0.01) in endometria from ewes receiving IFNT alone than in endometria from ewes receiving IFNTþMEL ( Table 2) . As depicted in Fig. 2 , intrauterine infusion of IFNT increased (P , 0.01) the total amount of PGs in the uterine lumen as well as the amounts of PGE2, PGF2a, and 6-ketoPGF1a. In contrast, infusion of the PTGS2 inhibitor MEL decreased (P , 0.01) the total amount of PGs and PGE2 but not PGF2a (P ¼ 0.16) or 6-keto-PGF1a (P ¼ 0.08) in the uterine lumen. Moreover, the levels of total PGs, PGE2, and 6-keto-PGF1a (P , 0.01) but not PGF2a (P ¼ 0.14) were lower (P , 0.01) in the uterine lumen of ewes receiving IFNT and MEL than in those of ewes receiving IFNT alone.
Immunoreactive PTGS2 protein was detected predominantly in the endometrial LE/sGE of all ewes in Study Two (Fig. 3) . PTGER2, PTGER4, and PTGFR proteins were detected at a lower level of abundance in the stroma and myometrium (data not shown). None of the treatments altered the abundance or distribution of PTGS2 or PTGER2, PTGER4, and PTGFR in the uterus.
Inhibition of PG Synthesis Affects the Ability of IFNT to Modulate Expression of Genes in the Endometrium (Study Two)
As summarized in Table 3 , intrauterine infusion of IFNT inhibited (P , 0.01) the cyclic increase in endometrial OXTR expression observed in CX ewes. Infusion of MEL alone increased OXTR mRNA levels in the endometrium, whereas infusion of IFNT inhibited OXTR expression in ewes coinfused with MEL (IFNT vs. IFNTþMEL; P . 0.10). Infusion of IFNT had no effect on PTGS1, PTGS2, and CBR1 expression but increased PTGES and PTGFS mRNA in the endometrium. Although IFNT infusion increased endometrial PTGER2 mRNA abundance, it decreased PTGFR and had no effect on PTGER4 mRNA. The PLN2, FGF2, and VEGF genes are all regulated by PGs in other cell types [42, 43] . Although expression of those genes was unchanged in endometria of ewes receiving MEL alone, IFNT increased the abundance of both PLIN2 and FGF2 mRNAs in the endometrium. Furthermore, co-infusion of MEL with IFNT inhibited the ability of IFNT to increase FGF2 expression.
As expected (Table 3) , infusion of IFNT substantially increased expression of two classical type I ISGs, the RSAD2 and ISG15 genes, in the endometrium (CX vs. IFNT, P , 0.01), which was decreased by co-infusion with MEL (IFNT vs. IFNTþMEL, P , 0.01). Furthermore, the overall abundance of those classical ISGs was lower (P , 0.01) in endometria of ewes receiving MEL than in those of ewes receiving the CX vehicle. Intrauterine infusions of MEL also affected expression of a number of progesterone-induced and IFNT-stimulated genes in the ovine endometrium ( Table 3 ). The abundance of CST3, GRP, HSD11B1, LGALS15, and IGFBP1 mRNAs was reduced in endometria of MEL ewes compared to those of CX ewes; note that the abundance of GRP, HSD11B1, and IGFBP1 mRNAs was lower (P , 0.01) (7.5-, 9.2-, and 27.9-fold, respectively) in endometria of MEL than in those of CX ewes. Furthermore, IFNT stimulation of a number of genes (CST3, CTSL, GRP, LGALS15, IGFBP1, SLC2A1, SLC5A1, SLC7A2) was reduced in ewes co-infused with IFNT and MEL compared to those in ewes treated with IFNT alone.
DISCUSSION
Results of the present studies support the hypothesis that PTGS2-derived PGs from the conceptus and/or endometrium are critical regulators of conceptus elongation during the periimplantation period of pregnancy in sheep. These results are in contrast to those from a 1982 report by LaCroix and Kann [44] in which systemic treatment of pregnant ewes from Days 7-22 postmating with either indomethacin (300 mg subcutaneous daily) or acetylsalicylic acid or aspirin (1 g intravenous daily), both nonselective PTGS inhibitors, resulted in a sharp diminution of endometrial and conceptus concentrations of PGs on Day 23 but did not affect establishment of pregnancy. They found conceptuses on Day 23 with no apparent differences between the embryo and placental weights of treated and control ewes [44] . Thus, they concluded that PGs did not have as important a biological role during early pregnancy in sheep as found in other species. Given estimates of the blood volume (49 ml/kg) and extracellular fluid volume (246 ml/kg) of an adult ewe, the doses of indomethacin and aspirin used in that study should have resulted in circulating levels that exceeded the half maximal inhibitory concentration for each compound. However, the ability of those compounds to gain entry into the uterine lumen and effectively inhibit PTGS2 in the trophectoderm of the elongating ovine conceptuses before Day 23 was not determined. During the onset of conceptus elongation (Days 12-13), blood flow to the uterus is relatively low, and the endometrial LE is intact, whereas blood flow is higher on Day 23, and much of the endometrial LE has been removed by the trophoblast giant binucleate cells [45] . Additionally, once-daily administration of PTGS inhibitors via a systemic route may not be sufficient to persistently inhibit the high level of PTGS2 activity and production of PGs by the ovine conceptus and endometrium during early pregnancy [14] , particularly given the half-life and metabolic clearance rates of indomethacin and aspirin. In the present Study One, the PTGS2 inhibitor MEL, administered directly into the uterine lumen from Days 8-14 postmating, retarded conceptus elongation, indicating that PTGS2-derived PGs do have an important physiological role in conceptus elongation and development during early pregnancy in sheep and likely other ruminants. During early pregnancy, both the endometrial LE/sGE and the conceptus trophectoderm express PTGS2. In sheep, elongation of the conceptus is coincident with PTGS2 expression in the endometrial epithelia and PG production by the conceptus [17] [18] [19] . During Days 12-16 of early pregnancy, sheep conceptuses in vitro release mainly cyclooxygenase metabolites including PGE2, PGF2a, and 6-keto-PGF1a, a metabolite and indicator of PGI2 [17, 19, 21] . Although not reported previously in sheep, results of the present studies revealed that receptors for PGE2 (PTGER2 and PTGER4) and PGF2a (PTGFR) were most abundant in the conceptus trophectoderm and endometrial epithelia in the ovine uterus during early pregnancy. Similarly, receptors for PGE2 and PGF2a are expressed in the endometrial epithelia and conceptus of cattle during early pregnancy [46] [47] [48] . Expression of PGI2 receptors (PTGIR) and nuclear PG receptors (peroxisome proliferating and activating receptors [PPARs]) were observed in both the endometrial epithelia and the conceptuses of sheep during early pregnancy [49] . Thus, effects of conceptus-and endometrium-derived PGs in ruminants may be autocrine, paracrine, or perhaps intracrine 
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given that PG receptors are present in both the conceptus and endometrium.
Results of Study Two indicate that PTGS2-derived PGs mediate, in part, the effects of progesterone and IFNT on the endometrium of the ovine uterus. Progesterone action is essential for conceptus survival and growth in sheep, because conceptuses were not present in uteri on Day 12 if bred ewes were treated with mifepristone (RU486), a progesterone receptor (PGR) antagonist, from Days 8-12 postmating [50] . Expression of many genes in the endometrial LE/sGE that regulate conceptus elongation is initiated between Days 10 and 12 postestrus/mating in both cyclic and pregnant ewes [8, 51] . Indeed, exposure of the ovine uterus to progesterone for 8-10 days induces the expression of many genes in the endometrial LE/sGE, including PTGS2 [12, 18, 52] . Results of the present study provide evidence that PTGS2-derived PGs mediate, in part, the effects of progesterone on the endometrium, because expression of a number of the progesterone-induced (CST3, GRP, HSD11B1, LGALS15, and IGFBP1) genes were reduced in the endometria of Day-14 cyclic ewes receiving intrauterine infusions of MEL from Day 8 postestrus compared to those from ewes receiving CX vehicle. The differential inhibitory effects that MEL has on PGE2 and 6-keto-PGF1a but not on PGF2a production by the endometrium may be due to differential effects on PTGES expression as well as the PTGS2-selective nature of the inhibitor and the actions of CBR1, which metabolizes PGE2 to PGF2a. Of particular note, the abundance of HSD11B1 and IGFBP1 mRNA in the endometrium was considerably reduced by intrauterine infusion of MEL compared to that in endometrium of CX. Those genes are expressed specifically in the endometrial LE/sGE of the ovine uterus beginning on Day 12 postestrus in cyclic ewes [12, 13] . In pregnant ewes, the increase in IGFBP1 and HSD11B1 expression by uterine LE/sGE between Days 10 and 14 of pregnancy and the subsequent decline in expression between Days 16 and 20 are temporally associated with the pattern of production of PGs by ovine conceptuses and amounts of PGs in the uterine lumen [12] [13] [14] . Furthermore, both HSD11B1 and IGFBP1 expression levels are upregulated by PGs in the ovine placenta and human uterine decidua, respectively [53] [54] [55] . Given that the IGFBP1 gene is upregulated by cAMP [55] , it is likely PGs such as PGE2 and/or PGI2, generated by the endometrial LE/sGE, increase IGFBP1 expression, given that their receptors are coupled to adenylate cyclase and generate cAMP that activates the protein kinase A (PKA) signaling pathways [56, 57] . Future studies are needed to determine if PGs from the endometrium and/or conceptus differentially regulate gene expression in the endometrium.
IFNT produced by conceptus trophectoderm abrogates uterine production of oxytocin-induced luteolytic pulses of PGF2a by inhibiting cyclic upregulation of the OXTR gene [58] ; however, neither PTGS2 expression nor basal production of PGF2a is inhibited by IFNT in ewes [18, 22] . The present P , 0.10 for the comparison; n.e. indicates no effect of treatment (P . 0.10).
1124 study confirmed those findings, as IFNT infusion inhibited OXTR expression without affecting PTGS2 and PTGS1 expression. In contrast, IFNT increased endometrial PTGS2 activity and also the amounts of total PGs, PGE2, and PGF2a in the uterine lumen. In fact, IFNs were found to stimulate PLA2 activity and synthesis of PGE2 and PGF2a in several different cell types over 25 years ago [26, 27] . In the present study, IFNT infusion increased PTGES and PTGFS mRNA abundance while it decreased HPGD mRNA, which encodes an enzyme that metabolizes PGs [48] . Collectively, the actions of IFNT on expression of genes involved in PG synthesis and catabolism would result in an increase in PG synthesis and secretion, which was observed in uterine flushings in the present study. Although IFNT increased the abundance of PG receptor mRNAs (PTGER2, PTGER4, and PTGFR), the abundance of the proteins encoded by those mRNAs was not different among endometria of ewes in the different treatment groups in Study Two. Results of this study clearly support the hypothesis that PTGS2-derived PGs from the endometrial LE and superficial glands have biological actions on a number of different endometrial cell types, given that receptors for PGE2 and PGF2a are present in both epithelial and stromal cells.
In the present study, IFNT infusion increased expression of a number of classical type I IFN-stimulated genes as well as progesterone-induced and IFNT-stimulated genes specifically expressed in the endometrial LE/sGE and/or GE [8, 9] . Furthermore, co-infusion of MEL along with IFNT decreased the magnitude of the effect of IFNT on many of those genes. Thus, PGs mediate, in part, the effects of IFNT on endometrial gene expression and function in the ruminant uterus. Although the receptors for IFNT (IFN-alpha subunit receptor 1 [IFNAR1] and IFNAR2) are most abundant on the endometrial epithelia, the canonical Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway mediating effects of IFNT in the stroma and GE are not active in the endometrial LE/sGE during pregnancy [59, 60] . Consequently, most classical ISGs (ISG15, RSAD2, MX1, B2M, and other genes) are not expressed or induced by IFNT in the endometrial LE/sGE of early pregnancy [61] [62] [63] , which may have implications in maternal tolerance of the conceptus allograft. Of note, Bott and coworkers [64] found that endocrine infusion of IFNT into the uterine vein of cyclic ewes increased ISG15 expression in the liver and corpus luteum but not endometrium. Moreover, Yang and coworkers [65] found that IFNT did not upregulate ISG15 expression in luteal cells culture in vitro. The noncanonical pathway mediating IFNT stimulation of genes in the endometrium has not been elucidated, but novel results from the present study suggest that PTGS2-derived PGs are part of the noncanonical pathway of IFNT action on the endometrium and perhaps corpus luteum.
One of the novel findings from the present studies is that endometrial PTGS2 activity is much higher in the endometrium of Day-14 pregnant CX-infused ewes than in that of Day-14 cyclic CX-infused ewes (3899.4 vs. 2.9 nmol/min) or in that of Day-14 cyclic IFNT-infused ewes (3899.4 vs. 157.6 nmol/ min). Thus, conceptus factors other than IFNT regulate PTGS2 activity in the endometrium. In the ovine uterus, we recently found that changes in PTGS2 abundance are coincident with HSD11B1 expression in the endometrial LE/sGE [12] . In Study Two, HSD11B1 mRNA abundance was much lower in the uteri of MEL-infused ewes. Both HSD11B1 expression and/or bioactivity in the ovine placenta are stimulated by a positive feedback loop involving cortisol and PGs as well as proinflammatory cytokines (interleukin 1 beta [IL1B] and tumor necrosis factor alpha [TNFA]) and progesterone [53, 54] . Future studies are needed to determine how conceptus and endometrial factors regulate PTGS2 activity in the endometrium during early pregnancy.
In summary, results of the present studies established that a) PTGS2-derived PGs regulate conceptus elongation via effects on the endometrium and/or conceptus trophectoderm itself and that b) PTGS2-derived PGs mediate, in part, effects of progesterone and IFNT on endometrial gene expression. These results and others support our overarching hypotheses that ovarian P4, conceptus IFNT, and PGs regulate endometrial functions important for conceptus elongation and implantation during the peri-implantation period of pregnancy. These results suggest that feed additives, drugs, or in vitro embryo culture additives that decrease conceptus or endometrial production of certain PGs or affect PG receptor expression or function may be detrimental to establishment of pregnancy. Indeed, PTGS2 expression in biopsy samples from Day-7 bovine blastocysts is a predictor of the successful development of that blastocyst to term and delivery of a live calf [66] . Moreover, treatment of Holstein heifers with MEL during pregnancy recognition reduced pregnancy rates [67] . These results add sheep to the list of species in which PGs, generated by PTGS2 in the endometrium, such as PGE2 and PGI2, are critical regulators of blastocyst implantation, decidualization, and uterine angiogenesis during pregnancy, e.g., mice, rats, hamsters, mink, and, likely, humans [68] [69] [70] . Future studies will focus on how specific PGs from the conceptus and endometrium regulate trophectoderm and endometrial function as well as perhaps trophectoderm differentiation during the peri-implantation stage of pregnancy.
